I dont think there are any issues with the cancer trials beside enrollment being slowed by COVID. I would like to get an update on enrollment, and have them focus on enrolling. But they have their hands full with COVID.

We have no choice but to focus on COVID right now. I was hoping that there would be some new info from the cancer guest, but I get the feeling he was brought on to show that we have a new expert in our midst.

Cancer trials will pick up steam again. The data we have seen is very good. Cancer is going to be a major revenue stream for CYDY IMO.